Data demonstrate efficacy of more flexible dose of regorafenib to relieve side-effects in mCRC patients

Medical oncologists administer anticancer drug regorafenib to try to improve overall survival in patients with metastatic colorectal cancer who have ceased to respond to standard therapy (known as refractory mCRC). However, some of the adverse events related to the use of this drug often limits its use in clinical practice. A study reported at the ESMO World Congress on Gastrointestinal Cancer 2019 suggests the usefulness of a more flexible dosing, which improves patients' quality of life without jeopardising efficacy. (1,2)

* This article was originally published here

Toyota to test solar panels for electric cars

What's not to like about this concept: high-efficiency solar cells gifting electric cars with mileage.

source https://www.lifetechnology.com/blogs/life-technology-news-blog/toyota-to-test-solar-panels-for-electric-cars

Data demonstrate efficacy of more flexible dose of regorafenib to relieve side-effects in mCRC patients

Medical oncologists administer anticancer drug regorafenib to try to improve overall survival in patients with metastatic colorectal cancer who have ceased to respond to standard therapy (known as refractory mCRC). However, some of the adverse events related to the use of this drug often limits its use in clinical practice. A study reported at the ESMO World Congress on Gastrointestinal Cancer 2019 suggests the usefulness of a more flexible dosing, which improves patients' quality of life without jeopardising efficacy. (1,2)

source https://www.lifetechnology.com/blogs/life-technology-news-blog/data-demonstrate-efficacy-of-more-flexible-dose-of-regorafenib-to-relieve-side-effects-in-mcrc-patients

Targeted therapy combination improves survival in patients with advanced bowel cancer

New data have shown for the first time that a combination of targeted therapies can improve survival in patients with advanced bowel cancer. Results of the BEACON CRC Phase III trial have shown that triple therapy targeting BRAF mutations in progressive metastatic colorectal tumours significantly improved overall survival and objective response compared to standard care.

source https://www.lifetechnology.com/blogs/life-technology-news-blog/targeted-therapy-combination-improves-survival-in-patients-with-advanced-bowel-cancer

Triplet-targeted therapy improves survival for patients with advanced colorectal cancer and BRAF mutations

The three-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival (OS) in patients with BRAF-mutated metastatic colorectal cancer (mCRC), according to results of the BEACON CRC Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

source https://www.lifetechnology.com/blogs/life-technology-news-blog/triplet-targeted-therapy-improves-survival-for-patients-with-advanced-colorectal-cancer-and-braf-mutations

Electric scooters: not so eco-friendly after all?

E-scooters touted as zero-carbon urban transport are flooding city streets worldwide, but just how green they are remains an open question.

source https://www.lifetechnology.com/blogs/life-technology-news-blog/electric-scooters-not-so-eco-friendly-after-all

Trump promises to reduce US drug prices to world's lowest

US President Donald Trump on Friday said his administration is working on an executive order to reduce US drug prices to match the lowest in the world.

source https://www.lifetechnology.com/blogs/life-technology-news-blog/trump-promises-to-reduce-us-drug-prices-to-worlds-lowest

Southern California reels from magnitude 7.1 quake

A quake with a magnitude of 7.1 jolted much of California, cracking buildings, setting fires, breaking roads and causing several injuries while seismologists warned that large aftershocks were expected to continue for days, if not weeks.

source https://www.lifetechnology.com/blogs/life-technology-news-blog/southern-california-reels-from-magnitude-7-1-quake

Amazon's Bezos finalizes divorce with $38 bn settlement: report

Amazon founder Jeff Bezos and MacKenzie Bezos finalized their divorce Friday to the tune of a $38-billion settlement, Bloomberg News reported.

source https://www.lifetechnology.com/blogs/life-technology-news-blog/amazons-bezos-finalizes-divorce-with-38-bn-settlement-report